2548 PUBLICATIONS
ANNÉE
JOURNAL
PREMIER AUTEUR
TITRE
ANNÉE2022
JOURNALJournal for immunotherapy of cancer
PREMIER AUTEURLecuelle J
TITREMER4 endogenous retrovirus correlated with better efficacy of anti-PD1/PD-L1 therapy in non-small cell lung cancer.
ANNÉE2022
JOURNALTechniques in vascular and interventional radiology
PREMIER AUTEURCazzato RL
TITREPercutaneous osteoplasty in long bones: Current status and assessment of outcomes.
ANNÉE2022
JOURNALBioconjugate chemistry
PREMIER AUTEURAdumeau P
TITRESite-Specific, Platform-Based Conjugation Strategy for the Synthesis of Dual-Labeled Immunoconjugates for Bimodal PET/NIRF Imaging of HER2-Positive Tumors.
ANNÉE2022
JOURNALSurgery
PREMIER AUTEURAddeo P
TITREUpfront versus resection after neoadjuvant chemotherapy for pancreatic adenocarcinomas with venous contact: comparative analysis of operative and survival outcomes.
ANNÉE2022
JOURNALBiomedicines
PREMIER AUTEURLamy L
TITREAntitumor Effect and Induced Immune Response Following Exposure of Hexaminolevulinate and Blue Light in Combination with Checkpoint Inhibitor in an Orthotopic Model of Rat Bladder Cancer.
ANNÉE2022
JOURNALCancers
PREMIER AUTEURFumet JD
TITREGenomic Instability Is Defined by Specific Tumor Microenvironment in Ovarian Cancer: A Subgroup Analysis of AGO OVAR 12 Trial.
ANNÉE2022
JOURNALMatrix biology : journal of the International Society for Matrix Biology
PREMIER AUTEURLoustau T
TITREModulating tenascin-C functions by targeting the MAtrix REgulating MOtif, "MAREMO".
ANNÉE2022
JOURNALCancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
PREMIER AUTEURThomas A
TITRE[Prognostic factors of acute radiodermatitis in breast cancer after adjuvant radiotherapy treated with RT3D or IMRT].
ANNÉE2022
JOURNALLung cancer (Amsterdam, Netherlands)
PREMIER AUTEURSlimano F
TITREAssociation between proton pump inhibitors and severe hematological toxicity in patients receiving pemetrexed-based anticancer treatment: The prospective IPPEM study.
ANNÉE2022
JOURNALClinical and experimental medicine
PREMIER AUTEURPrétet JL
TITREHigh levels of HPV16-L1 antibody but not HPV16 DNA load or integration predict oropharyngeal patient outcome: The Papillophar study.

Retrouvez aussi

Personnes
Equipes
Plateformes
Unités de recherche, établissements
Projets de recherche
Publications scientifiques